Altimmune Aktie - ALT

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

7,0399

Gebot

6,97

Fragen

7,03

Volumen

2.351.157

6,90 Tagesbereich 7,42

5,275 52-Wochen-Bereich 14,84

Marktkapitalisierung

500,71M

Handelsende

7,06

Handelsbeginn

7,12

Letzte Trade

7.02

Letzter Handelszeitpunkt

Finanzvolumen

US$ 16.842.505

VWAP

7,1635

Durchschnittliches Volumen (3 Mio.)

3.420.404

Ausgegebene Aktien

71.124.625

Dividendenrendite

Kurs-Gewinn-Verhältnis

-5,61

Gewinn pro Aktie (EPS)

-1,24

Erlöse

426k

Nettogewinn

-88,45M

Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the tre... Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH (non-alcoholic steatohepatitis). In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B virus (HBV). Mehr anzeigen

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.altimmune.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Altimmune Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALT. The last closing price for Altimmune was US$7,06. Over the last year, Altimmune shares have traded in a share price range of US$ 5,275 to US$ 14,84.

Altimmune currently has 71.124.625 shares in issue. The market capitalisation of Altimmune is US$502,14 million. Altimmune has a price to earnings ratio (PE ratio) of -5.61.

Gesamtfluss

Bärisch

Nettoprämie

-35k

Calls / Puts

150,00%

Käuf. / Verkä.

66,67%

OTM / ITM

150,00%

Sweeps

20,00%

Altimmune Added to Nasdaq Biotechnology Index

GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will be added to the Nasdaq Biotechnology...

Form 8-K - Current report

Altimmune to Present at the Cachexia Regulatory & Trials Update Workshop of the 17th International Conference of the Society on Sarcopenia, Cachexia & Wasting Disorders

GAITHERSBURG, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at...

Altimmune to Participate at Two Upcoming Investor Conferences

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will...

Altimmune Presents New Data on the Effect of Pemvidutide on Inflammatory Lipids in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at The Liver Meeting® 2024

Weekly subcutaneous doses of pemvidutide resulted in robust reductions in cardio-inflammatory, hepato-inflammatory and atherosclerotic lipids Findings support the potential benefit of pemvidutide...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.2399	3.52794117647	6.8	7.04	6.73	1538404	6.88035703	CS
4	-0.8601	-10.8873417722	7.9	8.03	6.19	2340640	7.00978655	CS
12	0.2199	3.22434017595	6.82	11.16	6.19	3420404	8.2548985	CS
26	0.7399	11.7444444444	6.3	11.16	5.275	2722241	7.55663076	CS
52	-2.9201	-29.3182730924	9.96	14.84	5.275	3421054	8.27759291	CS
156	0.2599	3.83333333333	6.78	23.49	2.09	2966532	8.10131814	CS
260	5.0599	255.550505051	1.98	35.1	1.6	2552266	9.68748864	CS

ALT - Frequently Asked Questions (FAQ)

What is the current Altimmune share price?

The current share price of Altimmune is US$ 7,0399

How many Altimmune shares are in issue?

Altimmune has 71.124.625 shares in issue

What is the market cap of Altimmune?

The market capitalisation of Altimmune is USD 502,14M

What is the 1 year trading range for Altimmune share price?

Altimmune has traded in the range of US$ 5,275 to US$ 14,84 during the past year

What is the PE ratio of Altimmune?

The price to earnings ratio of Altimmune is -5,61

What is the cash to sales ratio of Altimmune?

The cash to sales ratio of Altimmune is 1,16k

What is the reporting currency for Altimmune?

Altimmune reports financial results in USD

What is the latest annual turnover for Altimmune?

The latest annual turnover of Altimmune is USD 426k

What is the latest annual profit for Altimmune?

The latest annual profit of Altimmune is USD -88,45M

What is the registered address of Altimmune?

The registered address for Altimmune is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Altimmune website address?

The website address for Altimmune is www.altimmune.com

Which industry sector does Altimmune operate in?

Altimmune operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
EVAXEvaxion Biotech AS	US$ 5,99 (64,56%)	55,41M
ELABPMGC Holdings Inc	US$ 3,0901 (56,07%)	76,48M
PCLAPicoCELA Inc	US$ 4,60 (49,35%)	3,75M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
GODNUGolden Star Acquisition Corporation	US$ 3,11 (-75,82%)	17,51k
GODNGolden Star Acquisition Corporation	US$ 2,93 (-65,67%)	902,76k
NXTTNext Technology Holding Inc	US$ 1,37 (-54,93%)	2,56M
SGLYSingularity Future Technology Ltd	US$ 1,625 (-38,45%)	917,77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90,11 (-38,07%)	8
ACONAclarion Inc	US$ 0,0557 (28,94%)	811,91M
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
RIMEAlgorhythm Holdings Inc	US$ 0,0357 (4,69%)	284,97M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
NVDANVIDIA Corporation	US$ 142,62 (-3,12%)	232,88M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Altimmune Inc (ALT) Börsenkurse

Altimmune Inc (ALT)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Altimmune Inc

Option-Flow Altimmune (ALT)

Gesamtfluss

Bärisch

Nettoprämie

-35k

Calls / Puts

150,00%

Käuf. / Verkä.

66,67%

OTM / ITM

150,00%

Sweeps

20,00%

ALT Neueste Nachrichten

ALT - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen